At Endomag, we believe everyone deserves access to a better standard of cancer care. Many of the UK’s leading physicians and hospitals use our technologies to help women avoid breast surgery when it isn’t needed, and experience better outcomes when it is.

Our Sentimag® localisation system works alongside the Magseed® marker and Magtrace® lymphatic tracer to deliver non-radioactive tissue localisation and sentinel node biopsy procedures with pinpoint accuracy. 

To date, the Sentimag® platform has now helped over 200,000 patients access the best possible breast care, across more than 45 countries and six continents. Join the magnetic revolution today.